Passa al contenuto
Merck

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Nature biotechnology (1997-11-05)
R Zufferey, D Nagy, R J Mandel, L Naldini, D Trono
ABSTRACT

Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
MISSION® eGFP shRNA Control Vector, shRNA sequence targeting eGFP
Sigma-Aldrich
MISSION® pLKO.1-puro TurboGFP shRNA Control Plasmid DNA, shRNA sequence targeting tGFP